Millington Financial Advisors »

Gain Therapeutics shares owned by Millington Financial Advisors

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Millington Financial Advisors from 13F filings

Historical chart of Millington Financial Advisors investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Millington Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Millington Financial Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $29k 15k 1.95

More positions owned by Millington Financial Advisors

Spdr Series Trust State Street Spd (SPYG)
Spdr Index Shs Fds State Street Spd (SPDW)
Spdr Series Trust State Street Spd (SPYV)
Spdr Series Trust State Street Spd (SPMD)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Index Shs Fds State Street Spd (SPEM)
Etf Ser Solutions Defiance Quantum (QTUM)
Spdr Series Trust State Street Spd (SPSM)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Global X Fds Defense Tech Etf (SHLD)
Innovator Etfs Trust Us Equity Accele (XBAP)
Innovator Etfs Trust Us Eqt Aclrtd 9 (XBJL)
Stonex Group (SNEX)
Quanta Services (PWR)
NVIDIA Corporation (NVDA)

View all positions for Millington Financial Advisors

Top funds holding Gain Therapeutics

Marshall Wace
Potomac Capital Management
Susquehanna International
Jones Financial Companies, L.L
Vanguard Group
Cambridge Investment Research Advisors
DME Capital Management
Geode Capital Management
Vanguard Capital Management
GSA Capital Partners
Jane Street
Vanguard Fiduciary Trust
BlackRock
UBS Group
Cresset Asset Management

View all funds holding Gain Therapeutics